Brandon Vasquez • William Blair & Company

Question 1

Brandon Vasquez's questions to Zoetis Inc (ZTS) leadership • Q3 2024

Nov 4, 2024

Question

Brandon Vasquez of William Blair & Company questioned the drivers behind Simparica Trio's strong performance and market share gains amid rising competition, and asked for a breakdown of price versus volume for the companion animal business.

Answer

CEO Kristin Peck attributed Trio's success to its first-to-market advantage, comprehensive coverage, and strong customer partnerships, noting its 35% share in new puppies indicates future strength. CFO Wetteny Joseph specified that the company's 14% operational growth was driven by 8% volume and 6% price. For Trio specifically, growth was balanced with slightly more volume, aided by more targeted promotions and better price realization.

Ask Fintool Equity Research AI

Question 2

Brandon Vasquez's questions to Envista Holdings Corp (NVST) leadership • Q3 2024

Oct 30, 2024

Question

Brandon Vasquez of William Blair asked for details on the implant business's turnaround, specifically which investments are paying off. He also inquired about the relative performance of premium (Nobel) versus value implants in North America.

Answer

CEO Paul Keel detailed a three-tiered investment approach: immediate-term commercial investments, medium-term clinical education, and long-term new product development. He confirmed that value implants have seen three straight quarters of growth and that Nobel's quarter-over-quarter growth in North America has accelerated, narrowing the gap to the market.